Lourdes Millán Pérez Peña

Dr. Lourdes Millán Pérez Peña

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2020 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
JCJorge Cebada
Jorge Cebada
Martin Perez-SantosMartin Perez-Santos
Martin Perez-Santos
Cindy BandalaCindy Bandala
Cindy Bandala
EPEleazar Lara Padilla
Eleazar Lara Padilla
IHIrma Herrera-Camacho
Irma Herrera-Camacho
MAMaricruz Anaya-Ruiz
Maricruz Anaya-Ruiz
OX40 is an immune checkpoint in cancer and its presence in cancer is a good prognosis, making it a highly relevant target for the development of new immunotherapies. The patent literature reveals v...

2 February 2024 in Viruses
Verified
Journal Article
Open access
PDF file
Nora Hilda Rosas-MurrietaNora Hilda Rosas-Murrieta
Nora Hilda Rosas-Murrieta
ARAlan Rodriguez-Enriquez
Alan Rodriguez-Enriquez
IHIrma Herrera-Camacho
Irma Herrera-Camacho
LPLourdes Millán Pérez Peña
Lourdes Millán Pérez Peña
Gerardo Santos-LopezGerardo Santos-Lopez
Gerardo Santos-Lopez
JBJOSE FRANCISCO RIVERA BENITEZ
JOSE FRANCISCO RIVERA BENITEZ
This review presents comparative information corresponding to the progress in knowledge of some aspects of infection by the porcine epidemic diarrhea virus (PEDV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronaviruses. PEDV is an alphacoronavirus of great economic importance due to the million-dollar losses it generates in the pig industry. PEDV has many similarities to the SARS-CoV-2 betacoronavirus that causes COVID-19 disease. This review presents possible scenarios for SARS-CoV-2 based on the collected literature on PEDV and the tools or strategies currently developed for SARS-CoV-2 that would be useful in PEDV research. The speed of the study of SARS-CoV-2 and the generation of strategies to control the pandemic was possible due to the knowledge derived from infections caused by other human coronaviruses such as severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS). Therefore, from the information obtained from several coronaviruses, the current and future behavior of SARS-CoV-2 could be inferred and, with the large amount of information on the virus that causes COVID-19, the study of PEDV could be improved and probably that of new emerging and re-emerging coronaviruses.

20 May 2022 in Behavioural Neurology
Verified
Journal Article
Open access
PDF file
AAAna-Karina Aguilar-Peralta
Ana-Karina Aguilar-Peralta
AGAlejandro Gonzalez-Vazquez
Alejandro Gonzalez-Vazquez
CTConstantino Tomas-Sanchez
Constantino Tomas-Sanchez
VBVictor-Manuel Blanco-Alvarez
Victor-Manuel Blanco-Alvarez
DMDaniel Martinez-Fong
Daniel Martinez-Fong
BLBertha Alicia Leon-Chavez
Bertha Alicia Leon-Chavez
Exercise performance and zinc administration individually yield a protective effect on various neurodegenerative models, including ischemic brain injury. Therefore, this work was aimed at evaluating the combined effect of subacute prophylactic zinc administration and swimming exercise in a transient cerebral ischemia model. The prophylactic zinc administration (2.5 mg/kg of body weight) was provided every 24 h for four days before a 30 min common carotid artery occlusion (CCAO), and 24 h after reperfusion, the rats were subjected to swimming exercise in the Morris Water Maze (MWM). Learning was evaluated daily for five days, and memory on day 12 postreperfusion; anxiety or depression-like behavior was measured by the elevated plus maze and the motor activity by open-field test. Nitrites, lipid peroxidation, and the activity of superoxide dismutase (SOD) and catalase (CAT) were assessed in the temporoparietal cortex and hippocampus. The three nitric oxide (NO) synthase isoforms, chemokines, and their receptor levels were measured by ELISA. Nissl staining evaluated hippocampus cytoarchitecture and Iba-1 immunohistochemistry activated the microglia. Swimming exercise alone could not prevent ischemic damage but, combined with prophylactic zinc administration, reversed the cognitive deficit, decreased NOS and chemokine levels, prevented tissue damage, and increased Iba-1 (+) cell number. These results suggest that the subacute prophylactic zinc administration combined with swimming exercise, but not the individual treatment, prevents the ischemic damage on day 12 postreperfusion in the transient ischemia model.

1 February 2017 in European Journal of Pharmacology
Verified
Journal Article
Closed access
BPBertin Paiz-Candia
Bertin Paiz-Candia
Ángel A. IslasÁngel A. Islas
Ángel A. Islas
ASAlfredo Sánchez-Solano
Alfredo Sánchez-Solano
CMClaudia Mancilla-Simbro
Claudia Mancilla-Simbro
TSThomas Scior
Thomas Scior
ESEduardo M. Salinas-Stefanon
Eduardo M. Salinas-Stefanon

Verified
Journal Article
Open access
PDF file
Dalia González-EsparragozaDalia González-Esparragoza
Dalia González-Esparragoza
ACAlan Carrasco-Carballo
Alan Carrasco-Carballo
Nora Hilda Rosas-MurrietaNora Hilda Rosas-Murrieta
Nora Hilda Rosas-Murrieta
LPLourdes Millán Pérez Peña
Lourdes Millán Pérez Peña
FLFelix Luna
Felix Luna
IHIrma Herrera-Camacho
Irma Herrera-Camacho
Ermp1 is a putative metalloprotease from Schizosaccharomyces pombe and a member of the Fxna peptidases. Although their function is unknown, orthologous proteins from rats and humans have been associated with the maturation of ovarian follicles and increased ER stress. This study focuses on proposing the first prediction of PPI by comparison of the interologues between humans and yeasts, as well as the molecular docking and dynamics of the M28 domain of Ermp1 with possible target proteins. As results, 45 proteins are proposed that could interact with the metalloprotease. Most of these proteins are related to the transport of Ca2+ and the metabolism of amino acids and proteins. Docking and molecular dynamics suggest that the M28 domain of Ermp1 could hydrolyze leucine and methionine residues of Amk2, Ypt5 and Pex12. These results could support future experimental investigations of other Fxna peptidases, such as human ERMP1.